Your browser is no longer supported. Please, upgrade your browser.
Settings
NVAX Novavax, Inc. daily Stock Chart
NVAX [NASD]
Novavax, Inc.
Index- P/E- EPS (ttm)-0.50 Insider Own0.95% Shs Outstand462.20M Perf Week-8.06%
Market Cap241.08M Forward P/E- EPS next Y-0.29 Insider Trans1.99% Shs Float462.20M Perf Month-18.78%
Income-184.70M PEG- EPS next Q-0.11 Inst Own34.40% Short Float20.45% Perf Quarter-75.16%
Sales34.30M P/S7.03 EPS this Y20.40% Inst Trans-0.21% Short Ratio5.58 Perf Half Y-74.31%
Book/sh-0.44 P/B- EPS next Y25.60% ROA-72.40% Target Price1.46 Perf Year-71.02%
Cash/sh0.20 P/C2.61 EPS next 5Y0.00% ROE153.40% 52W Range0.49 - 2.58 Perf YTD-71.65%
Dividend- P/FCF- EPS past 5Y-10.30% ROI- 52W High-79.78% Beta2.04
Dividend %- Quick Ratio2.60 Sales past 5Y10.40% Gross Margin- 52W Low6.45% ATR0.04
Employees379 Current Ratio2.60 Sales Q/Q-41.30% Oper. Margin- RSI (14)25.54 Volatility5.26% 6.12%
OptionableYes Debt/Eq- EPS Q/Q19.90% Profit Margin- Rel Volume0.52 Prev Close0.53
ShortableNo LT Debt/Eq- EarningsMar 18 BMO Payout- Avg Volume16.93M Price0.52
Recom2.10 SMA20-6.88% SMA50-49.48% SMA200-66.82% Volume8,846,440 Change-1.71%
Feb-28-19Downgrade Piper Jaffray Overweight → Underweight $4.50 → $0.25
Dec-18-18Initiated Ladenburg Thalmann Buy $3
Dec-11-18Initiated Oppenheimer Outperform $4
Nov-26-18Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18Upgrade JP Morgan Underweight → Overweight
Mar-29-18Upgrade Seaport Global Securities Neutral → Buy $5
Mar-19-18Downgrade JP Morgan Neutral → Underweight
Mar-01-18Upgrade Citigroup Neutral → Buy
Jan-05-18Initiated B. Riley FBR, Inc. Buy $2.25
Dec-19-17Downgrade Citigroup Buy → Neutral
Oct-31-17Upgrade Citigroup Neutral → Buy
Aug-09-17Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
Sep-16-16Downgrade Piper Jaffray Overweight → Neutral
Sep-16-16Downgrade Ladenburg Thalmann Buy → Neutral
Sep-16-16Downgrade JP Morgan Overweight → Neutral
Sep-16-16Downgrade Citigroup Buy → Neutral
Apr-04-16Initiated Chardan Capital Markets Neutral $5.75
Apr-16-19 08:10AM  The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives Benzinga
Apr-15-19 02:43PM  Novavax faces delisting threat following failed drug trial American City Business Journals
Apr-13-19 09:38AM  The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Benzinga
Apr-12-19 09:20AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Novavax, Inc. ACCESSWIRE
Apr-11-19 05:45PM  Novavax (NVAX) Stock Moves -0.67%: What You Should Know Zacks
Apr-09-19 04:05PM  Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress GlobeNewswire
Apr-05-19 06:43PM  Edited Transcript of NVAX earnings conference call or presentation 18-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
05:45PM  Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know Zacks
Mar-27-19 05:45PM  Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
09:25AM  Four Healthcare Stocks Picking Up Speed on Wednesday ACCESSWIRE
Mar-22-19 02:06PM  3 Cheap Stocks to Buy That Are Worth Every Penny InvestorPlace -13.44%
08:46AM  Do Options Traders Know Something About Novavax (NVAX) Stock We Don't? Zacks
Mar-20-19 11:51AM  Why Novavax Is Soaring Today Motley Fool +16.38%
09:12AM  Does Novavax Have a Viable Path Forward? Motley Fool
07:00AM  What's Next for Novavax? Motley Fool
Mar-19-19 01:26AM  Novavax (NVAX) Q4 2018 Earnings Conference Call Transcript Motley Fool +5.91%
Mar-18-19 04:35PM  Novavax: 4Q Earnings Snapshot Associated Press
04:05PM  Novavax Reports Fourth Quarter and Year-End 2018 Financial Results GlobeNewswire
Mar-16-19 08:35AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Mar-13-19 03:00PM  These Four Healthcare Stocks Are Making Moves on Wednesday ACCESSWIRE
Mar-12-19 02:35PM  These Four Healthcare Stocks are Surging with Potential ACCESSWIRE
Mar-11-19 04:21PM  Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019 GlobeNewswire
Mar-08-19 07:30AM  The Device Market That Drove One Company From $2.50 to $65 Has a New Entrant ACCESSWIRE -5.86%
Mar-07-19 08:51AM  Is a Beat in Store for Catabasis (CATB) This Earnings Season? Zacks
Mar-06-19 09:52AM  Four Healthcare Stocks Seeing Gains On Wednesday ACCESSWIRE -5.09%
Mar-05-19 01:52PM  Why Novavax Stock Imploded in February Motley Fool -5.29%
Mar-04-19 11:34PM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks -10.18%
03:11PM  What another failed drug trial means for Novavaxs future American City Business Journals
08:46AM  Take a Poker Player's Approach to Playing Small Biotech Stocks TheStreet.com
Mar-03-19 07:09PM  The 3 Oldest Members of Biotech's Billion-Burned Club Motley Fool
Mar-01-19 08:50AM  The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis Benzinga
08:07AM  Can Novavax Convince the FDA Its Vaccine Deserves a Chance? Motley Fool
Feb-28-19 04:32PM  Why HP, Booking Holdings, and Novavax Slumped Today Motley Fool -66.90%
12:00PM  Novavax News: Why NVAX Stock Is Plunging Today InvestorPlace
11:06AM  Novavax Re-Enters Penny Stock Territory After Respiratory Disease Vaccine Flunks Late-Stage Trial Benzinga
10:39AM  Novavax Stock Is a Cautionary Tale for Speculators InvestorPlace
10:00AM  Why Novavax Stock Is Getting Crushed Today Motley Fool
07:43AM  Novavax shares crater 69% premarket after trial of ResVax misses its main goal MarketWatch
07:27AM  Novavax respiratory infection vaccine fails in late-stage trial Reuters
07:11AM  Novavax's respiratory infection vaccine fails in late-stage trial Reuters
07:00AM  Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax for Prevention of RSV Disease in Infants via Maternal Immunization GlobeNewswire
Feb-15-19 07:20AM  Research Report Identifies Novavax, Zillow Group, Broadridge Financial Solutions, Summit Midstream Partners, LP, Primoris Services, and RE/MAX with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-12-19 05:50PM  Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-06-19 05:50PM  Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
Jan-28-19 02:09PM  Analyst: This Medical Stock Could Triple Schaeffer's Investment Research
09:25AM  4 Healthcare Stocks Looking For A Healthy Start On Monday (1/28/19) ACCESSWIRE
08:31AM  Why Short-Sellers Raised Their Bets Against 2 Surging Biotech Stocks Motley Fool
Jan-21-19 08:30AM  A Biotech Play You Can't Afford To Miss ACCESSWIRE
Jan-19-19 09:17AM  3 High-Growth Stocks That Could Soar Motley Fool
Jan-17-19 10:15AM  Best Bottom Bouncing Opportunities ACCESSWIRE
Jan-14-19 09:04PM  Here's How Novavax Stock Gained 48.4% in 2018 Motley Fool -5.45%
08:00AM  Today's Research Reports on Trending Tickers: Novavax and Allogene Therapeutics ACCESSWIRE
Jan-13-19 09:00AM  3 Great Stocks Under $10 Motley Fool
Jan-11-19 09:30AM  Is Novavax (NVAX) Outperforming Other Medical Stocks This Year? Zacks
Jan-08-19 12:58PM  Top 3 Healthcare Penny Stocks for 2018 Investopedia
Jan-04-19 04:27PM  Why GameStop, Novavax, and Epizyme Jumped Today Motley Fool
02:53PM  Novavax kicks off 2019 with positive flu vaccine trial results American City Business Journals
10:10AM  These 4 Healthcare Stocks Are Making Moves ACCESSWIRE
09:24AM  Why Novavax's Stock Is Surging Today Motley Fool
08:00AM  Biotech Stocks Set to Start 2019 Off with a Bang ACCESSWIRE
07:59AM  The Daily Biotech Pulse: Novavax Reports Positive Influenza Vaccine Trial Data, Flexion Warns Of Revenue Shortfall, Retrophin's New CEO Benzinga
Jan-03-19 04:35PM  Novavax shares jump after positive results for flu vaccine MarketWatch
04:05PM  Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults GlobeNewswire
Jan-02-19 04:05PM  Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.07%
01:10PM  4 Healthcare Stocks Gaining Speed on Wednesday (1/2/19) ACCESSWIRE
Dec-31-18 08:49AM  The Most Promising Biotech Names Heading Into 2019 Investopedia
Dec-28-18 10:16AM  Small Cap Biotech Stocks on the Rise ACCESSWIRE
Dec-27-18 09:23AM  2 Biotech Penny Stocks to Buy Right Now Motley Fool -6.00%
Dec-25-18 06:17AM  What Type Of Shareholder Owns Novavax, Inc.s (NASDAQ:NVAX)? Simply Wall St.
Dec-23-18 06:27AM  Novavax, Inc. (NVAX): Hedge Funds Are Snapping Up Insider Monkey
Dec-13-18 06:55AM  Today's Research Reports on Trending Tickers: Novavax and Applied Genetic Technologies ACCESSWIRE -7.26%
Dec-11-18 06:00AM  3 Top Biotech Stocks to Buy in December Motley Fool
Dec-08-18 03:45PM  Here's What Pushed Novavax Stock Up 17.6% in November Motley Fool
Dec-04-18 04:05PM  Novavax Announces Leadership Promotions GlobeNewswire -7.31%
09:00AM  Some of December's Most Interesting Stocks ACCESSWIRE
Dec-03-18 02:00PM  2 Biotech Stocks Poised for Big Gains in 2019 Motley Fool +5.80%
08:10AM  Analysis: Positioning to Benefit within Symantec, ACADIA Pharmaceuticals, Novavax, BBX Capital, Paychex, and US Foods Holding Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Dec-02-18 11:33AM  Why Novavax Is Up 60% in 2018 Motley Fool
Nov-28-18 04:37PM  Why Novavax Soared Today Motley Fool +11.17%
Nov-27-18 06:55AM  Today's Research Reports on Trending Tickers: Novavax and ACADIA Pharmaceuticals ACCESSWIRE
Nov-26-18 12:55PM  4 Healthcare Stocks Seeing New Highs On Monday ACCESSWIRE +7.56%
Nov-17-18 05:33PM  Edited Transcript of NVAX earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-18 04:05PM  Novavax Expands Leadership with Several Key Management Promotions GlobeNewswire
01:44PM  Does Novavax Incs (NASDAQ:NVAX) CEO Pay Reflect Performance? Simply Wall St.
Nov-08-18 02:20PM  What Novavax needs for success as it advances blockbuster vaccine candidates American City Business Journals -6.60%
Nov-07-18 08:00PM  Novavax (NVAX) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:55PM  Novavax: 3Q Earnings Snapshot Associated Press
04:05PM  Novavax Reports Third Quarter 2018 Financial Results GlobeNewswire
07:20AM  Q3 Earnings Outlook For Novavax Benzinga
Nov-02-18 06:50PM  Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
Nov-01-18 04:15PM  Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018 GlobeNewswire +7.95%
04:05PM  Novavax Appoints Rachel King to Board of Directors GlobeNewswire
Oct-31-18 10:51AM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks
Oct-24-18 08:25AM  Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD Fundamental Analysis, Key Performance Indications GlobeNewswire -8.15%
Oct-15-18 08:00AM  Novavax Shares Gain as its Lead Compounds Move Forward, Analysts Review and Target ACCESSWIRE
Oct-14-18 06:32AM  3 Top Small-Cap Stocks to Buy in October Motley Fool
Oct-10-18 06:44PM  Top 3 Healthcare Penny Stocks for 2018 Investopedia -6.34%
01:59PM  Here's Why Novavax Gained 20.5% in September Motley Fool
10:30AM  Major Biotech Announcements Moving the Market ACCESSWIRE
Oct-09-18 06:00AM  3 Top Small-Cap Stocks to Buy in October Motley Fool
Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein recombinant nanoparticle vaccine with aluminum phosphate as an adjuvant that is in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase II clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as allows immunization with much lower doses of antigen. The company also develops RSV F vaccine for older adults in Phase II clinical trial, and healthy children between two and six years of age in Phase I clinical trial. In addition, it develops nanoparticle vaccine candidates for clinic testing against ebola virus in Phase I clinical trial, as well as MERS coronavirus in animals; and combination respiratory vaccine to protect against influenza and RSV. The company has a clinical development agreement with Bill & Melinda Gates Foundation. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
King Rachel K.DirectorMar 27Buy0.5344,00023,31122,000Mar 28 04:21 PM
King Rachel K.DirectorMar 27Buy0.5342,00022,25242,000Mar 28 04:21 PM
Glenn Gregory MPresident, R&DJul 31Buy0.8813,00711,44660,218Aug 01 05:11 PM
Glenn Gregory MPresident, R&DMay 14Buy1.6420,00032,80047,211May 15 11:17 AM
Trizzino JohnSVP, CBO and CFOMay 14Buy1.6450,00081,995138,965May 15 11:16 AM
Erck Stanley CPresident and CEOMay 14Buy1.65100,000164,620328,279May 15 11:13 AM